GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Shares Outstanding (EOP)

OptiBiotix Health (LSE:OPTI) Shares Outstanding (EOP) : 91.19 Mil (As of Jun. 2023)


View and export this data going back to 2011. Start your Free Trial

What is OptiBiotix Health Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. OptiBiotix Health's shares outstanding for the quarter that ended in Jun. 2023 was 91.19 Mil.

OptiBiotix Health's quarterly shares outstanding stayed the same from Dec. 2022 (91.19 Mil) to Jun. 2023 (91.19 Mil).

OptiBiotix Health's annual shares outstanding increased from Dec. 2021 (87.94 Mil) to Dec. 2022 (91.19 Mil). It means OptiBiotix Health issued new shares from Dec. 2021 to Dec. 2022 .


OptiBiotix Health Shares Outstanding (EOP) Historical Data

The historical data trend for OptiBiotix Health's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Shares Outstanding (EOP) Chart

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.33 84.72 87.94 87.94 91.19

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.94 87.94 88.07 91.19 91.19

Competitive Comparison of OptiBiotix Health's Shares Outstanding (EOP)

For the Biotechnology subindustry, OptiBiotix Health's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Shares Outstanding (EOP) falls into.



OptiBiotix Health Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


OptiBiotix Health  (LSE:OPTI) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


OptiBiotix Health Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (LSE:OPTI) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.